Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening.

[1]  P. Choyke,et al.  MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. , 2020, The New England journal of medicine.

[2]  E. Schaeffer,et al.  The Cost of Prostate Biopsies and their Complications: A Summary of Data on All Medicare Fee-for-Service Patients over 2 Years. , 2019, Urology practice.

[3]  J. Hugosson,et al.  Long-term Outcomes for Men in a Prostate Screening Trial with an Initial Benign Prostate Biopsy: A Population-based Cohort. , 2019, European urology oncology.

[4]  M. Terris,et al.  Population-based outcomes of men with a single negative prostate biopsy: Importance of continued follow-up among older patients. , 2019, Urologic oncology.

[5]  Eric A. Miller,et al.  Extended follow‐up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial , 2018, BJU international.

[6]  A. Farmer,et al.  Standard and competing risk analysis of the effect of albuminuria on cardiovascular and cancer mortality in patients with type 2 diabetes mellitus , 2018, Diagnostic and Prognostic Research.

[7]  Marco Borghesi,et al.  Complications After Systematic, Random, and Image-guided Prostate Biopsy. , 2017, European urology.

[8]  B. Vainer,et al.  Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study. , 2017, The Lancet. Oncology.

[9]  F. Chinegwundoh,et al.  Update on prostate cancer in black men within the UK , 2014, Ecancermedicalscience.

[10]  E. Şerefoğlu,et al.  How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? , 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[11]  T. Brand,et al.  Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort , 2011, Prostate cancer.

[12]  David Chia,et al.  Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.

[13]  M Schumacher,et al.  Efficient Risk Set Sampling when a Time-dependent Exposure Is Present , 2009, Methods of Information in Medicine.

[14]  M. Meng,et al.  Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy. , 2008, The Journal of urology.

[15]  J. Gohagan,et al.  Repeat prostate biopsy in the Prostate, Lung, Colorectal and Ovarian cancer screening trial , 2007, BJU international.